54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 06
12:30 UTC
|
SATL
Satellogic
|
◎ Target | Andres Sheppard ★☆☆☆☆ #3129 | Overweight | $10.00→ $9.00-10.0% |
|
Aug 06
12:30 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Ami Fadia ★★★☆☆ #2084 | Buy | $236.00→ $240.00+1.7% |
|
Aug 06
12:30 UTC
|
RUN
Sunrun
|
◎ Target | Brian Lee not yet tracked | Buy | $18.00→ $15.00-16.7% |
|
Aug 06
12:30 UTC
|
PTRN
Pattern Group
|
◎ Target | Bernie McTernan ★★☆☆☆ #2452 | Buy | $24.00→ $29.00+20.8% |
|
Aug 06
12:30 UTC
|
POWI
Power Integrations
|
◎ Target | David Williams ★☆☆☆☆ #3023 | Buy | $90.00→ $80.00-11.1% |
|
Aug 06
12:30 UTC
|
PAYC
Paycom Software
|
◎ Target | Matthew VanVliet ★★★★★ #215 | Neutral | $135.00→ $195.00+44.4% |
|
Aug 06
12:30 UTC
|
PAYC
Paycom Software
|
◎ Target | Allan Verkhovski ★★★☆☆ #1363 | Buy | $160.00→ $230.00+43.8% |
|
Aug 06
12:30 UTC
|
MRAM
Everspin Tech
|
◎ Target | Neil Young not yet tracked | Buy | $18.50→ $19.00+2.7% |
|
Aug 06
12:30 UTC
|
MIRM
Mirum Pharmaceuticals
|
◎ Target | Swayampakula Ramakanth ★★☆☆☆ #2778 | Buy | $185.00→ $140.00-24.3% |
|
Aug 06
12:30 UTC
|
MIAX
Miami International
|
◎ Target | Chris Brendler ★★☆☆☆ #2880 | Buy | $61.00→ $62.00+1.6% |
|
Aug 06
12:30 UTC
|
MGNI
Magnite
|
◎ Target | Tyler DiMatteo ★★★☆☆ #1016 | Buy | $20.00→ $27.00+35.0% |
|
Aug 06
12:30 UTC
|
MGNI
Magnite
|
◎ Target | Barton Crockett ★★★★☆ #650 | Buy | $39.00→ $40.00+2.6% |
|
Aug 06
12:30 UTC
|
METC
Ramaco Resources
|
◎ Target | Brian Lee not yet tracked | Neutral | $13.00→ $11.00-15.4% |
|
Aug 06
12:30 UTC
|
MELI
MercadoLibre
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1703 | Overweight | $2,150.00→ $2,300.00+7.0% |
|
Aug 06
12:30 UTC
|
LPX
Louisiana-Pacific
|
◎ Target | Susan Maklari ★★★★☆ #930 | Sell | $66.00→ $74.00+12.1% |
|
Aug 06
12:30 UTC
|
LLY
Eli Lilly and Company
|
◎ Target | Carter Gould ★★★★★ #236 | Overweight | $1,350.00→ $1,410.00+4.4% |
|
Aug 06
12:30 UTC
|
LFMD
LifeMD
|
◎ Target | David Larsen ★★★★☆ #561 | Buy | $10.00→ $9.00-10.0% |
|
Aug 06
12:30 UTC
|
KVYO
Klaviyo
|
◎ Target | Nick Altmann ★★★★★ #320 | Buy | $30.00→ $25.00-16.7% |
|
Aug 06
12:30 UTC
|
KVYO
Klaviyo
|
◎ Target | Billy Fitzsimmons ★★★★★ #204 | Overweight | $26.00→ $23.00-11.5% |
|
Aug 06
12:30 UTC
|
JOBY
Joby Aviation
|
◎ Target | Chris Pierce ★☆☆☆☆ #3145 | Buy | $18.00→ $15.00-16.7% |
|
Aug 06
12:30 UTC
|
IRON
Disc Medicine
|
◎ Target | Douglas Tsao ★★★☆☆ #1638 | Buy | $118.00→ $120.00+1.7% |
|
Aug 06
12:30 UTC
|
HUBS
HubSpot
|
◎ Target | Nick Altmann ★★★★★ #320 | Buy | $300.00→ $250.00-16.7% |
|
Aug 06
12:30 UTC
|
GPN
Global Payments
|
◎ Target | Will Nance ★★★★☆ #920 | Neutral | $82.00→ $94.00+14.6% |
|
Aug 06
12:30 UTC
|
FLUT
Flutter Entertainment
|
◎ Target | Bernie McTernan ★★☆☆☆ #2452 | Buy | $135.00→ $110.00-18.5% |
|
Aug 06
12:30 UTC
|
EYPT
Eyepoint Pharmaceuticals
|
◎ Target | Yi Chen ★★☆☆☆ #2405 | Buy | $30.00→ $27.00-10.0% |
|
Aug 06
12:30 UTC
|
EXTR
Extreme Networks
|
◎ Target | Mike Genovese not yet tracked | Buy | $39.00→ $38.00-2.6% |
|
Aug 06
12:30 UTC
|
EXPE
Expedia Group
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1703 | Neutral | $255.00→ $310.00+21.6% |
|
Aug 06
12:30 UTC
|
EXPE
Expedia Group
|
◎ Target | Jake Fuller ★★★★☆ #605 | Buy | $330.00→ $350.00+6.1% |
|
Aug 06
12:30 UTC
|
ELVN
Enliven Therapeutics
|
◎ Target | Salveen Richter ★★★☆☆ #1400 | Buy | $67.00→ $80.00+19.4% |
|
Aug 06
12:30 UTC
|
EBAY
eBay
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1703 | Neutral | $110.00→ $106.00-3.6% |
|
Aug 06
12:30 UTC
|
EBAY
eBay
|
◎ Target | Bernie McTernan ★★☆☆☆ #2452 | Buy | $122.00→ $135.00+10.7% |
|
Aug 06
12:30 UTC
|
DNTH
Dianthus Therapeutics
|
◎ Target | Swayampakula Ramakanth ★★☆☆☆ #2778 | Buy | $130.00→ $158.00+21.5% |
|
Aug 06
12:30 UTC
|
DASH
DoorDash
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1703 | Overweight | $230.00→ $260.00+13.0% |
|
Aug 06
12:30 UTC
|
CRCL
Circle Internet Group
|
◎ Target | John Todaro ★☆☆☆☆ #3213 | Buy | $150.00→ $127.00-15.3% |
|
Aug 06
12:30 UTC
|
CRCL
Circle Internet Group
|
◎ Target | Mike Colonnese ★☆☆☆☆ #3066 | Buy | $115.00→ $104.00-9.6% |
|
Aug 06
12:30 UTC
|
CPRI
Capri
|
◎ Target | Brooke Roach ★★★☆☆ #1920 | Neutral | $21.00→ $18.00-14.3% |
|
Aug 06
12:30 UTC
|
CPRI
Capri
|
◎ Target | Robert Drbul ★★★★☆ #770 | Buy | $30.00→ $25.00-16.7% |
|
Aug 06
12:30 UTC
|
CMC
Commercial Metals
|
◎ Target | Katja Jancic ★★★☆☆ #2099 | Market Perform | $77.00→ $80.00+3.9% |
|
Aug 06
12:30 UTC
|
CLFD
Clearfield
|
◎ Target | Ryan Koontz ★☆☆☆☆ #3105 | Buy | $52.00→ $40.00-23.1% |
|
Aug 06
12:30 UTC
|
CHYM
Chime Financial
|
◎ Target | Will Nance ★★★★☆ #920 | Buy | $26.00→ $33.00+26.9% |
|
Aug 06
12:30 UTC
|
CHYM
Chime Financial
|
◎ Target | Andrew Bauch ★★★★☆ #567 | Outperform | $28.00→ $32.00+14.3% |
|
Aug 06
12:30 UTC
|
CDNA
CareDx
|
◎ Target | Mark Massaro ★★★★★ #173 | Buy | $45.00→ $60.00+33.3% |
|
Aug 06
12:30 UTC
|
BMBL
Bumble
|
◎ Target | Alexandra Steiger not yet tracked | Neutral | $5.00→ $3.50-30.0% |
|
Aug 06
12:30 UTC
|
BLLN
Billiontoone
|
◎ Target | Mark Massaro ★★★★★ #173 | Buy | $142.00→ $130.00-8.5% |
|
Aug 06
12:30 UTC
|
BLBD
Blue Bird
|
◎ Target | Gregory Lewis ★☆☆☆☆ #3072 | Buy | $80.00→ $95.00+18.8% |
|
Aug 06
12:30 UTC
|
ARQT
Arcutis Biotherapeutics
|
◎ Target | Serge Belanger ★★★☆☆ #1891 | Buy | $36.00→ $40.00+11.1% |
|
Aug 06
12:30 UTC
|
APP
AppLovin
|
◎ Target | Clark Lampen ★★☆☆☆ #2453 | Buy | $640.00→ $574.00-10.3% |
|
Aug 06
12:30 UTC
|
APP
AppLovin
|
◎ Target | Bernie McTernan ★★☆☆☆ #2452 | Buy | $700.00→ $500.00-28.6% |
|
Aug 06
12:30 UTC
|
APP
AppLovin
|
◎ Target | Omar Dessouky ★★★☆☆ #1312 | Buy | $705.00→ $430.00-39.0% |
|
Aug 06
12:30 UTC
|
APP
AppLovin
|
◎ Target | Eric Sheridan ★★★☆☆ #1710 | Neutral | $585.00→ $465.00-20.5% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.